Meyka Pro banner
Vanguard Health Care ETF

Stay Updated with the Latest Vanguard Health Care ETF VHT News in Real Time

Find VHT news now at Meyka AI. Stay informed with the latest Vanguard Health Care ETF stocks updates, including price news, market analysis, and expert insights.

VHTAMEX
Financial ServicesAsset Management
$327.49
$0.21(0.06%)
U.S. Market opens in NaNh NaNm
Greater Manchester NHS Trust Declares Critical Incident as 350 Staff Strike
📅 8 hours ago

Greater Manchester NHS Trust Declares Critical Incident as 350 Staff Strike

Greater Manchester NHS trust declares critical incident as 350 staff strike over overtime pay dispute with NHS Professionals agency on August 24, 26, and 28.

Read more 12
Fromm Recalls 5,800 Cases of Wet Dog Food Over Metal Contamination Risk
📅 9 hours ago

Fromm Recalls 5,800 Cases of Wet Dog Food Over Metal Contamination Risk

Fromm Family Foods recalls 5,800 cases of wet dog food due to metal contamination. Two products affected: Turkey Pâté and Milo’s Meatloaf Pâté. No illnesses reported.

Read more 12
Heranba Industries (NSE: HERANBA) Jumps 9.5% to ₹180.60 on ₹25 Crore Agrochem Unit Investment
📅 12 hours ago

Heranba Industries (NSE: HERANBA) Jumps 9.5% to ₹180.60 on ₹25 Crore Agrochem Unit Investment

Heranba Industries shares jumped 9.53% to ₹180.60 on Monday, August 24, 2026. The rally followed a Q1 FY27 profit turnaround alongside a fresh ₹25 crore investment plan. Heranba Industries also returned to profitability after a weak Q4 FY26. Q1 FY27 Results Drive the Rally Heranba Industries (HERANBA.NS) posted consolidated net profit of ₹7.14 crore in…

Read more 12
Sonova (SIX: SOON) Launches Phonak EON AI Hearing Platform to Drive Growth Targets
📅 16 hours ago

Sonova (SIX: SOON) Launches Phonak EON AI Hearing Platform to Drive Growth Targets

Sonova launched Phonak EON on August 24, introducing its third real-time AI hearing platform. The Swiss hearing-care company designed EON to improve speech understanding and reduce listening effort. The launch strengthens Phonak’s premium hearing-aid portfolio during an important growth phase. Sonova said EON combines proprietary AI with improved design and connectivity. Phonak EON Adds Smaller…

Read more 12
Bitcoin Price Jumps Over 24% in a Week, Breaks $78,000 Amid $2.7 Billion Liquidations
📅 16 hours ago

Bitcoin Price Jumps Over 24% in a Week, Breaks $78,000 Amid $2.7 Billion Liquidations

Bitcoin surged more than 24% in the week ending August 24, 2026, pushing above $78,000 as bullish momentum returned to the crypto market. The sharp move also triggered around $2.7 billion in short liquidations, adding further buying pressure. With Bitcoin now nearing the $80,000 level, investors are watching whether fresh demand can keep the rally…

Read more 12
MCX, NBCC India, Paras Defence, P&G Health Set for Ex-Dividend Trading This Week
📅 18 hours ago

MCX, NBCC India, Paras Defence, P&G Health Set for Ex-Dividend Trading This Week

MCX leads this week’s latest ex-dividend stocks, joined by NBCC India, Paras Defence, and P&G Health. Multi Commodity Exchange of India has fixed August 28, 2026, as the record date for a ₹8 final dividend. NBCC India, Paras Defence, and Procter & Gamble Health have record dates scheduled for August 27–28.  Investors must hold shares…

Read more 12
Study: Babies Born Under Sugar Rationing Face Lower Cancer Risk Decades Later
📅 23 hours ago

Study: Babies Born Under Sugar Rationing Face Lower Cancer Risk Decades Later

Study of 64,761 UK adults shows those exposed to sugar rationing in infancy had lower cancer risk decades later. Researchers found reductions in liver, prostate, lung, rectal, and breast cancers.

Read more 12
Bitcoin Cash Surges 23% to $274.84 as Japan Licensing Fuels Institutional Demand
📅 1 day ago

Bitcoin Cash Surges 23% to $274.84 as Japan Licensing Fuels Institutional Demand

Bitcoin Cash jumped 23.3% to $274.84 on August 23, 2026, after Japan approved its first new crypto trading license in four years, enabling regulated access for professional investors.

Read more 12
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
📅 1 day ago

Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win

Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.

Read more 12

VHT News FAQ